Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study

Cancer Chemotherapy and Pharmacology
Martin van den BentDavid Reardon

Abstract

Patients with recurrent glioblastoma (rGBM) have a poor prognosis. Epidermal growth factor receptor (EGFR) gene amplification is present in ~ 50% of glioblastomas (GBMs). Depatuxizumab mafodotin (depatux-m), formerly ABT-414, is an antibody-drug conjugate that preferentially binds cells with EGFR amplification, is internalized and releases a potent antimicrotubule agent, monomethyl auristatin F (MMAF). Here we report the safety, pharmacokinetics, and efficacy of depatux-m monotherapy at the recommended Phase 2 dose (RPTD) in patients with EGFR-amplified, rGBM. M12-356 (NCT01800695) is an open-label study with three escalation and expansion cohorts. Sixty-six patients with EGFR-amplified, rGBM were treated with depatux-m monotherapy at 1.25 mg/kg intravenously every 2 weeks. Adults with measurable rGBM, who were bevacizumab-naïve, with EGFR amplification were eligible. Among 66 patients, median age was 58 years (range 35-80). All patients were previously treated with radiotherapy/temozolomide. The most common adverse events (AEs) were eye related (91%), including blurred vision (65%), dry eye (29%), keratitis, and photophobia (27% each). Grade 3/4 AEs occurred in 42% of all patients, and ocular Grade 3/4 AEs occurred in 33% of p...Continue Reading

References

Jan 29, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Koji YoshimotoPaul S Mischel
Mar 22, 2008·Neuro-oncology·Kathleen R LambornUNKNOWN North American Brain Tumor Consortium
Nov 20, 2008·Journal of Neuro-oncology·Teri N KreislLauren E Abrey
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentThierry Gorlia
Jun 6, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B NeynsJ De Greve
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Nov 28, 2012·International Journal of Radiation Oncology, Biology, Physics·Arnab ChakravartiMinesh Mehta
Oct 15, 2013·Cell·Cameron W BrennanUNKNOWN TCGA Research Network
Feb 18, 2015·Frontiers in Oncology·Emily PadfieldKathreena M Kurian
Mar 4, 2015·Molecular Cancer Therapeutics·Edward B ReillyAndrew M Scott
Oct 20, 2015·Journal of Neuro-oncology·J J RaizerUNKNOWN Brain Tumor Trials Collaborative
Nov 6, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Joshua Seth EatonChristopher J Murphy
Feb 3, 2016·Critical Reviews in Oncology/hematology·Katharina SeystahlMichael Weller
Feb 6, 2016·Molecular Cancer Therapeutics·Andrew C PhillipsEdward B Reilly

❮ Previous
Next ❯

Citations

Apr 13, 2019·Neuropathology and Applied Neurobiology·L BerteroP Cassoni
May 23, 2019·CA: a Cancer Journal for Clinicians·Wafik S El-DeiryJohn L Marshall
May 28, 2019·Neuro-oncology·Pim J FrenchMartin van den Bent
Nov 22, 2019·Nature·Floris P BarthelUNKNOWN GLASS Consortium
Apr 27, 2019·Der Pathologe·B Malzkorn, G Reifenberger
Nov 10, 2018·Neuro-oncology·Elisa AquilantiPriscilla K Brastianos
Jan 13, 2019·Targeted Oncology·Zhuanglin LiChangjiang Huang
Apr 27, 2018·The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica·Alessia PellerinoRoberta Rudà
Oct 3, 2018·Frontiers in Pharmacology·Edouard Alphandéry
Jul 10, 2020·Neuro-oncology Advances·Caterina BrighiSimon Puttick
Aug 22, 2018·Acta Neuropathologica Communications·Michael W RonellenfitschPatrick N Harter
Feb 25, 2020·Journal of Oncology·Adrianna RutkowskaPiotr Rieske
Sep 18, 2020·Pharmaceuticals·Nicolas JoubertCaroline Denevault-Sabourin
Feb 24, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew B LassmanMartin J van den Bent
Aug 28, 2020·Molecular Cancer Therapeutics·Mark G AndersonEdward B Reilly
Feb 19, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Paul M J ClementMartin J van den Bent
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shalini Sundramurthi ChelliahIshwar Parhar
Jun 26, 2021·Pharmacology & Therapeutics·Yiming JinAndrew J Wiemer
Oct 23, 2021·Experimental and Therapeutic Medicine·Ani-Simona SevastreAnica Dricu
Nov 15, 2020·International Journal of Pharmaceutics·Elias da Silva SantosJosimar O Eloy

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
biopsy

Clinical Trials Mentioned

NCT01800695
NCT02573324
NCT02343406

Software Mentioned

Vysis

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.